Geneos Wealth Management’s Ares Capital ARCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$907K Sell
50,354
-5,448
-10% -$105K 0.02% 531
2025
Q4
$1.13M Sell
55,802
-1,640
-3% -$33.1K 0.03% 473
2025
Q3
$1.17M Sell
57,442
-988
-2% -$22K 0.03% 448
2025
Q2
$1.28M Sell
58,430
-49,489
-46% -$1.05M 0.03% 468
2025
Q1
$2.45M Buy
107,919
+56,444
+110% +$1.28M 0.04% 442
2024
Q4
$1.13M Buy
51,475
+970
+2% +$20.9K 0.04% 390
2024
Q3
$1.06M Buy
50,505
+3,405
+7% +$70.7K 0.04% 400
2024
Q2
$982K Sell
47,100
-220
-0.5% -$4.6K 0.04% 363
2024
Q1
$985K Sell
47,320
-1,644
-3% -$33.3K 0.05% 353
2023
Q4
$981K Sell
48,964
-32,579
-40% -$635K 0.05% 326
2023
Q3
$1.59M Buy
81,543
+1,528
+2% +$29.6K 0.08% 248
2023
Q2
$1.5M Buy
80,015
+30,953
+63% +$572K 0.08% 252
2023
Q1
$897K Sell
49,062
-23,667
-33% -$447K 0.05% 314
2022
Q4
$1.34M Buy
72,729
+7,008
+11% +$132K 0.08% 227
2022
Q3
$1.11M Sell
65,721
-14,144
-18% -$273K 0.08% 238
2022
Q2
$1.51M Buy
79,865
+11,124
+16% +$219K 0.07% 245
2022
Q1
$1.44M Buy
68,741
+4,421
+7% +$94.2K 0.06% 271
2021
Q4
$1.36M Buy
64,320
+817
+1% +$17K 0.05% 317
2021
Q3
$1.31M Buy
63,503
+9,552
+18% +$191K 0.05% 318
2021
Q2
$1.07M Buy
53,951
+6,029
+13% +$117K 0.04% 346
2021
Q1
$930K Sell
47,922
-558
-1% -$10K 0.03% 438
2020
Q4
$880K Buy
48,480
+14,307
+42% +$222K 0.04% 381
2020
Q3
$468K Sell
34,173
-5,385
-14% -$76.6K 0.02% 447
2020
Q2
$551K Buy
39,558
+366
+0.9% +$4.94K 0.03% 389
2020
Q1
$442K Buy
39,192
+307
+0.8% +$5.18K 0.03% 397
2019
Q4
$724K Buy
38,885
+669
+2% +$12.4K 0.04% 359
2019
Q3
$716K Sell
38,216
-3,669
-9% -$68K 0.04% 339
2019
Q2
$751K Sell
41,885
-1,953
-4% -$34.6K 0.05% 325
2019
Q1
$751K Buy
43,838
+4,805
+12% +$80.5K 0.05% 321
2018
Q4
$608K Buy
39,033
+4,262
+12% +$70.5K 0.05% 335
2018
Q3
$597K Buy
34,771
+1,555
+5% +$26.7K 0.04% 346
2018
Q2
$546K Sell
33,216
-1,367
-4% -$22.5K 0.04% 315
2018
Q1
$548K Sell
34,583
-684
-2% -$10.8K 0.05% 294
2017
Q4
$554K Sell
35,267
-1,785
-5% -$29K 0.05% 292
2017
Q3
$607K Buy
37,052
+36
+0.1% +$583 0.06% 272
2017
Q2
$606K Buy
37,016
+780
+2% +$13.1K 0.06% 261
2017
Q1
$659K Buy
36,236
+18,687
+106% +$323K 0.07% 222
2016
Q4
$289K Buy
17,549
+1,601
+10% +$25.2K 0.04% 365
2016
Q3
$247K Buy
15,948
+2,357
+17% +$36.1K 0.03% 402
2016
Q2
$193K Buy
13,591
+1,014
+8% +$15K 0.03% 451
2016
Q1
$189K Buy
+12,577
New +$173K 0.03% 442

Other funds holding ARCC

Geneos Wealth Management's ARCC Position: Q1 2026 in Review

Geneos Wealth Management reduced its Ares Capital (ARCC) stake by 9.8% in Q1 2026, selling an estimated $105K and leaving 50,354 shares worth $907K. The position accounts for 0.02% of the portfolio, ranked #531.

Geneos Wealth Management first reported a position in ARCC in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.45M in Q1 2025. 807 funds tracked by Wall St. Rank hold ARCC as of Q1 2026.

  • Geneos Wealth Management held 50,354 shares of Ares Capital worth $907K as of Q1 2026.
  • Geneos Wealth Management sold 5,448 Ares Capital shares in Q1 2026, an estimated $105K.
  • Ares Capital made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #531 holding.
  • Geneos Wealth Management first reported a position in Ares Capital in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Ares Capital position peaked at $2.45M in Q1 2025.
  • 807 funds tracked by Wall St. Rank held Ares Capital as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.